1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Germinomatous Germ Cell Tumor: new trials by email Literature Review of Germinomatous Germ Cell Tumor trials Research Report on Germinomatous Germ Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Durvalumab, Tremelimumab - Germ Cell Tumor, Nonseminomatous Germ Cell Tumor | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 30 | 2017-05-15 | 2026-09-18 |
Dysgerminoma (1) · Germinoma (1) · Neoplasms, Germ Cell and Embryonal (1) · Nonseminomatous germ cell tumor (1) · Seminoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1)
durvalumab (1) · tremelimumab (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)
Samuel Funt, MD (1)